Golani, Gonen https://orcid.org/0000-0003-4792-6807
Seal, Manas
Kar, Mrityunjoy https://orcid.org/0000-0002-7910-9580
Hyman, Anthony A. https://orcid.org/0000-0003-0851-704X
Goldfarb, Daniella https://orcid.org/0000-0001-5714-7159
Safran, Samuel https://orcid.org/0000-0002-0798-1492
Funding for this research was provided by:
Volkswagen Foundation (197/98)
Article History
Received: 7 October 2024
Accepted: 9 May 2025
First Online: 2 June 2025
Competing interests
: AA Hyman is the founder and SAB member of Dewpoint Therapeutics. The remaining authors declare no competing interests.